Published on
July 6, 2026
- 12:00 GMT
xDot Medical Receives FDA Approval to Initiate Pivotal IDE Trial of Its Large-Bore Vascular Closure System
MAPLE GROVE, MN, UNITED STATES, July 6, 2026 /EINPresswire.com/ -- xDot Medical today announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational Device Exemption (IDE) application to initiate its pivotal …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
